Study guide
17.1 Yeasts: Candida, Cryptococcus, and Malassezia
ASCP Microbiology Technologist M ASCP
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current M(ASCP) Exam Facts 1.2 CAT, Scoring, Retakes, and CMP 1.3 Eligibility Routes and Clinical Experience
2 Preanalytic: Collection and Transport
2.1 Patient Identification and Specimen Labeling 2.2 Specimen Collection, Sterile Technique, and Blood Cultures 2.3 Transport Devices, Atmosphere, Time, and Temperature
3 Preanalytic: Processing, Media, and Incubation
3.1 Prioritization, Rejection, and Specimen Preparation 3.2 Media Types, Components, and Selection 3.3 Inoculation, Incubation Conditions, and Slide Preparation
4 Preanalytic: Stains
4.1 Gram Stain: Procedure, Principle, and Interpretation 4.2 Acid-Fast and Modified Acid-Fast Stains 4.3 KOH, Calcofluor-White, Trichrome, Giemsa, and Acridine Orange
5 Bacteriology: Blood and Bone Marrow
5.1 Blood Culture Systems and Rapid Identification 5.2 Bloodstream Pathogens and Skin Flora Significance 5.3 Endocarditis, Bone Marrow Pathogens, and Pathogenicity
6 Bacteriology: CSF and Sterile Body Fluids
6.1 CSF Sources and Acute Meningitis Pathogens 6.2 Shunt Infections, CSF Correlates, Antigen and Molecular Methods 6.3 Sterile Body Fluids: Pathogens, Flora, and Molecular Methods
7 Bacteriology: Respiratory Tract
7.1 Lower Respiratory Specimens, CAP, and HAP Pathogens 7.2 Cystic Fibrosis Pathogens and Quantitative Reporting 7.3 Upper Respiratory: Pharyngitis, Otitis, Sinusitis, Antigen/Molecular
8 Bacteriology: Gastrointestinal Tract
8.1 Enteric Pathogens: Culture and Colony Morphology 8.2 Clostridioides difficile, Shiga Toxin, and Serotyping 8.3 Helicobacter pylori Detection and GI Pathogenicity
9 Bacteriology: Skin, Soft Tissue, and Bone
9.1 Skin, Soft Tissue, and Bone Pathogens 9.2 Bite Wounds and Zoonotic Infections 9.3 SST Pathogenicity and Virulence Mechanisms
10 Bacteriology: Genital Tract and Urine
10.1 Genital Flora and Vaginitis Pathogens 10.2 Neisseria gonorrhoeae, Chlamydia trachomatis, GBS, and Mycoplasma 10.3 Urinary Pathogens, Colony Counts, and Urinalysis Correlation
11 Bacteriology: Identification Methods
11.1 Colony Morphology and Rapid Presumptive Tests 11.2 Conventional Biochemicals and Commercial Kits 11.3 Automated Methods, MALDI-TOF MS, Molecular, and 16S Sequencing
12 Bacteriology: Antimicrobial Susceptibility and Resistance
12.1 Microbroth Dilution, Disk Diffusion, and Gradient Diffusion 12.2 Phenotypic Detection of Resistance 12.3 Antibiotic Classes, Intrinsic Resistance, and Genetic Markers
13 Bacteriology: Resistance Screening and Select Agents
13.1 MRSA/MSSA, VRE, ESBL/CRE Screening 13.2 BSL-3 Pathogens and Select-Agent Presumptive Identification 13.3 Laboratory Response Network and Select-Agent Pathogenicity
14 Mycobacteriology and Nocardia
14.1 Specimens, Major Pathogens, and Disease States 14.2 Acid-Fast Reaction, Colony Morphology, and Growth Characteristics 14.3 Identification Methods, Direct Molecular Detection, and TB Therapy
15 Virology
15.1 Respiratory, Vesicle, Meningitis, and GI Viruses 15.2 Hepatitis, HIV, and Immunocompromised-Host Viruses 15.3 Direct Detection Methods and HPV Cervical Screening
16 Parasitology
16.1 Blood, Tissue, and Brain Protozoa 16.2 Intestinal/Urogenital Protozoa and Helminths 16.3 Microscopy, Antigen/Molecular Detection, Insects and Arthropods
17 Mycology
17.1 Yeasts: Candida, Cryptococcus, and Malassezia 17.2 Dimorphic Fungi and Dermatophytes 17.3 Mucorales, Hyaline Molds, Pneumocystis, and Identification Methods
18 Serology
18.1 Immunoglobulin Response and Antigen-Antibody Methods 18.2 Viral Serodiagnosis: Hepatitis, EBV, HIV, CMV, Rubella, Measles 18.3 Treponema, Borrelia, and TB Infection Serodiagnosis
19 Laboratory Operations: Postanalytic Procedures and Quality
19.1 Documentation, Critical Values, Corrected Reports, and Public Health 19.2 Quality Control, Root-Cause Analysis, and POCT 19.3 Proficiency Testing, Competency, and Accreditation
20 Laboratory Operations: Safety, Mathematics, and Instrumentation
20.1 Biosafety, PPE, Bloodborne Pathogens, and SDS 20.2 Emergencies and Packaging/Transportation of Specimens 20.3 Laboratory Mathematics and Instrumentation
17.1 Yeasts: Candida, Cryptococcus, and Malassezia
Key Takeaways Explain This Topic AI
A yeast from blood, CSF, or another sterile site is a critical isolate; source (superficial vs deep vs blood) decides whether you are looking at colonization or invasive disease.
The historic Candida albicans screen is a true germ tube without a constriction at the mother cell; CHROMagar, PNA-FISH, and MALDI-TOF now give species-level ID, and C. auris is an infection-control emergency.
Cryptococcus is a narrow-based budding encapsulated yeast; India ink or mucicarmine shows the capsule, and cryptococcal antigen (CrAg) on serum or CSF is more sensitive than ink.
Malassezia from skin shows spaghetti-and-meatballs KOH morphology and is lipid-dependent — overlay sterile olive oil or it will not grow.
Do not treat a germ-tube-negative yeast as 'not Candida'; C. glabrata, C. parapsilosis, C. krusei, and C. auris are germ-tube negative and clinically important.
Last updated: August 2026
17.1 Yeasts: Candida, Cryptococcus, and Malassezia
Quick Answer: Match the yeast to the specimen and the one test that names it. Candida from mucosa or blood: germ tube historically for C. albicans , then CHROMagar, PNA-FISH, or MALDI; treat C. auris as an infection-control emergency. Cryptococcus from CSF or blood: narrow-based budding capsule (India ink/mucicarmine) and cryptococcal antigen (CrAg). Malassezia from skin or lipid-TPN blood: spaghetti-and-meatballs KOH and olive-oil overlay because the organism is lipid-dependent.
Official outline III.D Mycology (guideline 2025-09-25) tests yeasts as a core M topic. Dematiaceous molds, Microsporidium , and antifungal AST are SM-only — do not spend M study time on black-mold species lists or MIC interpretation. What the M exam does expect is that you can place a yeast in the correct clinical compartment, pick the right rapid test, and not confuse Candida , Cryptococcus , and Malassezia with one another or with the dimorphic yeasts in the next section.
Specimen source comes first
Yeasts are unicellular fungi that reproduce by budding (blastoconidia). Some species also form pseudohyphae (constricted filaments of elongated buds) or true hyphae. The bench question is not "is yeast present?" — Gram stains and KOH answer that — but what does this source mean?
Superficial sources — skin scrapings, nail clippings, oral swabs, and vaginal secretions — recover Candida and Malassezia as agents of mucocutaneous disease or as colonizers. A vaginal wet prep with clue cells and a fishy odor points to bacterial vaginosis, not yeast; budding yeasts and pseudohyphae on KOH support candidal vulvovaginitis. Skin KOH that shows short hyphae plus spores is tinea versicolor ( Malassezia ), not dermatophyte hyphae.
Deep and systemic sources — tissue, abscess aspirates, BAL, CSF, and other sterile fluids — change the meaning of the same morphology. Yeast in CSF is Cryptococcus until proven otherwise. Yeast in a liver or spleen biopsy in a neutropenic patient is invasive candidiasis. Isolation from a sterile site is never reported as "probable contaminant" without a documented clinical conversation.
Blood is its own compartment. Yeast in a blood-culture bottle is a critical value. Candida spp. cause most candidemia; C. auris , Cryptococcus , and Malassezia (neonates on lipid TPN) are the exam-relevant exceptions. Note the bottle type (standard aerobic vs mycosis/F or lysis-centrifugation), time to positivity, and the Gram-stain picture — round buds, elongated buds with pseudohyphae, or tiny oval yeasts — before a colony exists. Aerobic bottles recover most Candida ; some Malassezia and Cryptococcus isolates prefer the fungal bottle or prolonged incubation.
Compartment Typical sources Yeasts to think first Do not dismiss as
Superficial Skin, nails, vagina, oral mucosa Candida , Malassezia Colonization vs infection by clinical picture
Deep / sterile CSF, tissue, BAL, fluids Cryptococcus , invasive Candida "Just yeast"
Blood Blood-culture bottles, catheters Candida spp., C. auris , Cryptococcus , Malassezia Skin flora; yeast in blood is significant
Candida species
C. albicans is still the most common clinical isolate, but non- albicans species have risen with azoles, ICU catheters, and TPN. Disease states you must map to the organism:
Mucocutaneous: thrush, denture stomatitis, esophagitis (especially HIV), vulvovaginitis, diaper dermatitis, chronic mucocutaneous candidiasis.
Invasive: candidemia, endophthalmitis, hepatosplenic (chronic disseminated) candidiasis after neutrophil recovery, prosthetic-valve endocarditis, catheter UTI.
Species clues: C. parapsilosis and biofilms on TPN catheters; C. glabrata in older and azole-exposed patients (no true hyphae or pseudohyphae on cornmeal Tween 80 — only tiny blastoconidia); C. krusei intrinsically fluconazole-resistant, so the identification drives therapy even though full antifungal AST is SM-only; C. tropicalis in neutropenia; C. auris in healthcare outbreaks.
Germ tube (historic, still tested). A light inoculum of colony is incubated in serum (or plasma) at 37°C for 2–3 hours. A true germ tube of C. albicans (and C. dubliniensis ) is a filament that leaves the mother cell without a constriction . C. tropicalis can throw a "pseudogerm tube" with a constriction at the junction — a classic M trap. Over-incubation past 3 hours produces false filaments. Many laboratories have replaced daily germ tubes with CHROMagar and MALDI-TOF, but the outline still expects the principle. C. dubliniensis is germ-tube positive; it often fails to grow at 42°C, whereas C. albicans grows — MALDI now ends that argument.
CHROMagar Candida uses chromogenic substrates so mixed yeasts declare themselves by color on one plate: C. albicans green ( C. dubliniensis often darker green), C. tropicalis metallic blue, C. krusei pink, rough, and spreading, C. glabrata smaller mauve colonies. C. auris is not reliably identified by color — colonies may be cream, pink, or pale. Never rule out C. auris because the plate "doesn't look like it."
PNA-FISH and MALDI-TOF. Peptide nucleic acid FISH probes applied to a drop of positive blood-culture broth can separate C. albicans from a C. glabrata group in hours and shorten time to targeted therapy. MALDI-TOF MS is the workhorse species ID from a colony and, in some workflows, from a blood-culture pellet. Older MALDI libraries misidentified C. auris as C. haemulonii , Saccharomyces , or another rare yeast. If the isolate is from a healthcare facility, fails to ID cleanly, or is unexpectedly hardy, use a current C. auris -capable library or send molecular confirmation and notify infection prevention the same shift .
C. auris infection control is tested as laboratory practice, not as an MIC table. Place the patient on contact precautions in a single room. Clean the environment with a sporicidal (bleach-class / EPA List P or C. difficile List K) agent; ordinary quaternary ammonium products fail. Screen axilla and groin of contacts and unit neighbors. Report to public health. Do not wait for antifungal susceptibility results — those methods are SM-only on the 2025-09-25 outline — to start isolation.
Cornmeal agar with Tween 80 (Dalmau plate) still earns exam items: C. albicans shows terminal chlamydospores and clustered blastoconidia along pseudohyphae; C. glabrata shows only small blastoconidia; C. parapsilosis shows sage-brush or giant-cell morphology; C. krusei shows elongated cells that look like a "crossed matchstick." Biochemical panels (API 20C AUX, Vitek yeast cards) and urease (negative for most Candida , positive for Cryptococcus and Trichosporon ) complete conventional ID when MALDI is down.
Cryptococcus species
C. neoformans (worldwide, aged pigeon droppings, AIDS-defining meningitis) and C. gattii (soil and eucalyptus; more often immunocompetent hosts; Pacific Northwest and tropics) are round to oval yeasts with a polysaccharide capsule. On Gram stain they may look like poorly staining "ghost" cells. India ink or nigrosin on CSF shows a clear halo around a narrow-based budding yeast. Mucicarmine stains the capsule red in tissue. Narrow-based budding is the contrast with Blastomyces (broad-based budding) in the next section.
Cryptococcal antigen (CrAg) on serum or CSF is more sensitive than India ink (ink misses many low-burden cases). Lateral-flow assays are the current bench standard; latex agglutination is the historic method. Titers can be followed. False positives are uncommon; rheumatoid factor and Trichosporon cross-reactivity are the classic caveats, and very high titers can prozone — dilute and repeat if the picture is cryptococcal but the undiluted CrAg is negative. A positive CSF CrAg with lymphocytic pleocytosis, high protein, and low-normal glucose is diagnostic while culture is still incubating.
Culture: creamy colonies on Sabouraud; bird-seed (niger seed) agar turns brown to black because phenoloxidase makes melanin. Urease positive. Inositol assimilation positive. Capsule is enhanced on chocolate agar or in CO2; poorly encapsulated strains still antigen-positive. Disease states: subacute meningitis/meningoencephalitis, cryptococcoma, pulmonary nodules, cutaneous lesions in disseminated disease, and IRIS after ART is started.
Malassezia species
M. furfur complex causes tinea (pityriasis) versicolor: hypo- or hyperpigmented trunk patches that fluoresce dull yellow under a Wood lamp. KOH of scrapings shows short hyphae and round spores — spaghetti and meatballs . The organism is lipophilic . Unsupplemented Sabouraud often yields nothing unless you overlay sterile olive oil or use a lipid medium (Dixon, Leeming-Notman). In the nursery, M. furfur causes catheter-related fungemia in infants receiving lipid TPN; tell the clinician to stop the lipid and pull the line. Direct Gram stain of blood or the catheter may already show tiny oval yeasts — culture without oil is a false-negative trap. M. pachydermatis (dogs) is less lipid-dependent and can grow without overlay; most human M. furfur isolates will not.
Seborrheic dermatitis and folliculitis are additional Malassezia disease states. Do not set up a dermatophyte workup and call it tinea corporis when the KOH is spaghetti and meatballs rather than long septate dermatophyte hyphae.
Bench pitfalls that cost points
Germ-tube negative does not mean "not Candida ." It means not C. albicans / C. dubliniensis . Cryptococcus does not make pseudohyphae on cornmeal and is urease positive; Candida is usually urease negative. Malassezia that "won't grow" is usually a missing lipid, not a dead organism. C. auris is identified by an updated library plus infection-control action, not by CHROMagar color. Keep dimorphic tissue yeasts ( Histoplasma small intracellular; Blastomyces broad-based; Sporothrix cigar bodies) out of this yeast algorithm — they convert with temperature and are the next section.